These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11952169)

  • 1. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.
    Slominska EM; Smolenski RT; Szolkiewicz M; Leaver N; Rutkowski B; Simmonds HA; Swierczynski J
    Mol Cell Biochem; 2002 Feb; 231(1-2):83-8. PubMed ID: 11952169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?
    Rutkowski B; Slominska E; Szolkiewicz M; Smolenski RT; Striley C; Rutkowski P; Swierczynski J
    Kidney Int Suppl; 2003 May; (84):S19-21. PubMed ID: 12694300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.
    Slominska EM; Rutkowski P; Smolenski RT; Szutowicz A; Rutkowski B; Swierczynski J
    Mol Cell Biochem; 2004 Dec; 267(1-2):25-30. PubMed ID: 15663182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure.
    Slominska EM; Kowalik K; Smolenski RT; Szolkiewicz M; Rutkowski P; Rutkowski B; Swierczynski J
    Pediatr Nephrol; 2006 Jun; 21(6):800-6. PubMed ID: 16604373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.
    Lenglet A; Liabeuf S; Bodeau S; Louvet L; Mary A; Boullier A; Lemaire-Hurtel AS; Jonet A; Sonnet P; Kamel S; Massy ZA
    Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27854278
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary Excretion of
    Deen CPJ; Veen AV; Gomes-Neto AW; Geleijnse JM; Berg KJBD; Heiner-Fokkema MR; Kema IP; Bakker SJL
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of N-methyl-2-pyridone-5-carboxamide--A nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells.
    Slominska EM; Smolenski RT; Osborne F; Swierczynski J; Yacoub MH
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):259-62. PubMed ID: 16021911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?
    Yoshimura N; Yamada K; Ono T; Notoya M; Yukioka H; Takahashi R; Wakino S; Kanda T; Itoh H
    Clin Exp Nephrol; 2023 Nov; 27(11):901-911. PubMed ID: 37490135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Excretion of
    Deen CPJ; van der Veen A; Gomes-Neto AW; Geleijnse JM; Borgonjen-van den Berg KJ; Heiner-Fokkema MR; Kema IP; Bakker SJL
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32041099
    [No Abstract]   [Full Text] [Related]  

  • 10. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
    Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA
    Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of purine nucleotides in uremic fluids and tissues.
    Rutkowski B; Rutkowski P; Słomińska E; Swierczyński J
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S7-10. PubMed ID: 20797575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between uremic toxins and oxidative stress in patients with chronic renal failure.
    Rutkowski P; Słominska EM; Szołkiewicz M; Aleksandrowicz E; Smolenski RT; Wołyniec W; Renke M; Wisterowicz K; Swierczynski J; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):243-8. PubMed ID: 17469035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
    Slominska EM; Carrey EA; Foks H; Orlewska C; Wieczerzak E; Sowinski P; Yacoub MH; Marinaki AM; Simmonds HA; Smolenski RT
    J Biol Chem; 2006 Oct; 281(43):32057-64. PubMed ID: 16920716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
    Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure.
    Carrey EA; Smolenski RT; Edbury SM; Laurence A; Marinaki AM; Duley JA; Zhu L; Goldsmith DJ; Simmonds HA
    Clin Chim Acta; 2003 Sep; 335(1-2):117-29. PubMed ID: 12927693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP.
    Slominska EM; Szolkiewicz M; Smolenski RT; Rutkowski B; Swierczynski J
    Nephron; 2002 Jun; 91(2):286-91. PubMed ID: 12053067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
    Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular toxicity of nicotinamide metabolites.
    Rutkowski B; Rutkowski P; Słomińska E; Smolenski RT; Swierczyński J
    J Ren Nutr; 2012 Jan; 22(1):95-7. PubMed ID: 22200423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1-Methylnicotinamide: The Mysterious Anti-aging Actor in Renal Transplantation.
    Nejabati HR; Roshangar L
    Curr Pharm Des; 2023; 29(10):723-731. PubMed ID: 37005540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.